CUV News: Clinuvel Pharmaceuticals (ASX:CUV) shareholders have earned a 14% CAGR over the last five years - 31st Mar 2023, 8:34am

[annb0t]

While Clinuvel Pharmaceuticals Limited (ASX:CUV) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 12% in the last quarter. But that doesn't change the fact that the returns over the last five years have been pleasing. After all, the share price is up a market-beating 92% in that time.

So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns.

View o...

>>> Read more: Clinuvel Pharmaceuticals (ASX:CUV) shareholders have earned a 14% CAGR over the last five years